{
    "Trade/Device Name(s)": [
        "TRU Legionella"
    ],
    "Submitter Information": "Meridian Bioscience, Inc.",
    "510(k) Number": "K113190",
    "Predicate Device Reference 510(k) Number(s)": [
        "K982238"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "MJH"
    ],
    "Summary Letter Date": "January 26, 2012",
    "Summary Letter Received Date": "January 27, 2012",
    "Submission Date": "October 28, 2011",
    "Regulation Number(s)": [
        "21 CFR 866.3300"
    ],
    "Regulation Name(s)": [
        "Haemophilus spp. Serological Reagents"
    ],
    "Analyte Class(es)": [
        "microbiology"
    ],
    "Analyte(s)": [
        "Legionella pneumophila serogroup 1 antigen"
    ],
    "Specimen Type(s)": [
        "Human urine"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [],
    "Method(s)/Technology(ies)": [
        "Rapid lateral-flow immunoassay"
    ],
    "Methodologies": [
        "Immunoassay"
    ],
    "Submission Type(s)": [
        "Assay"
    ],
    "Document Summary": "FDA 510(k) summary for TRU Legionella rapid lateral-flow immunoassay for detection of Legionella pneumophila serogroup 1 antigen in human urine",
    "Indications for Use Summary": "Aid in diagnosis of Legionella pneumophila serogroup 1 infection via qualitative detection of antigens in urine specimens from patients with pneumonia symptoms; results used with clinical evaluation and other diagnostics",
    "fda_folder": "Microbiology"
}